SAN FRANCISCO, Jan 8, 2018 /PRNewswire/ — A surge in mergers and acquisitions (M&A) by life sciences companies is expected in 2018, prompted by increased competition from new entrants and new sources of capital, and the change in US corporate tax laws, particularly a lower tax rate…